{"name":"Shanghai Vitalgen BioPharma Co., Ltd.","slug":"shanghai-vitalgen-biopharma-co-ltd","ticker":"","exchange":"","domain":"shanghaivitalgen.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Cardiovascular","slug":"cardiovascular","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"VGR-R01","genericName":"VGR-R01","slug":"vgr-r01","indication":"Hypertension","status":"phase_3"}]}],"pipeline":[{"name":"VGR-R01","genericName":"VGR-R01","slug":"vgr-r01","phase":"phase_3","mechanism":"VGR-R01 is a small molecule drug that targets the renin-angiotensin system.","indications":["Hypertension"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiqgJBVV95cUxNanRobzAyR0tPeS1qWEM0SjBkaUh5NmlmeWx5dVUwYXNFTU0zM25VT1ZVMWRGc0tnc3liQ2xIdmIxZ0dTTFV5VlJpUXBPZVJiRGEzT1d6NHdPMUVWWGtua2M1WlMtZGJnNi03TWpCa0VrRFRXTEQxUVVDRzBOSjVjUHV4djNrVG02cFZHSzc4UE5GWXVPamZEWmlDdkxRaW1MS3lLdmNjcUZOZThVOG5ZUXpod0FHMFRFdWltclBhUS1lUUMtZ0hUZkprMFRQbXJxYkluZ2tDWFZrY3pTYWZMVTV2dVBuUnhaT3JHTWpiNHJBei1ZYURmOWxBc0Q1OVhacmFHQ1ZNMEdwWFEtWi1YVmtNR1NUODVMQlBLdkhIR1BCaWxFWExzTVN3?oc=5","date":"2026-03-31","type":"pipeline","source":"Barchart.com","summary":"Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, Alnylam Pharma, CSL Behring, uniQure, Novo Nordisk - Barchart.com","headline":"Hemophilia B Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Pfizer, Spark Therapeutics, Sanofi, A","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPZnpyZUV2UVVjLTdCcFE2UEhSM2VWbXFWXzQ0OFl3dWFCRlNiTFRVdjh6VzktUThyMk1KWEZqVkl1UEZIcG1OTjNCM184M1hPTnpFX0FEdzk3bWNLaFkwQzFlZXZfemZTeXllOVFTZlhBT213cEExaWNOMGRSTG5CTlBBczhfeXJ0VFlIT0ttY29DRXh1YUliVTNTcHB3Skk?oc=5","date":"2026-03-26","type":"regulatory","source":"openPR.com","summary":"Acquired Hemophilia A Pipeline 2026: FDA Approvals and Clinical - openPR.com","headline":"Acquired Hemophilia A Pipeline 2026: FDA Approvals and Clinical","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMi3wFBVV95cUxOaFNyT1N0RC1JZXlmRHR1cTlTTDMydEZRMkdYZFVSVkxqUTRVYTdNeUF1SFFMeUdzTm8xS2xadU9odTRKU2RxT1BxVzRvTTN4XzNGdFpWSmQxbnFJOGJrSENjUkJkS2thOHR1ZlY0LThRNndESkNxeGRrT3BwaE1QN21FZ2szRDkybkcwMGFvVVBONEJFdnVXQU1ZMW9udnc5c3BZb3UxQm1yeHFITENweVpLVmMwWVJiWmhwOUhzbkVIWjF1RGstUVNwWkV6T1pxWDRsNV9GaUpIM1JaOThv?oc=5","date":"2025-05-12","type":"pipeline","source":"prnewswire.com","summary":"Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting - prnewswire.com","headline":"Grit Biotechnology Presents Multiple Scientific Breakthroughs at ASGCT 2025 Annual Meeting","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxQdGtHS0prWERqRG4tNUhDaUU5WmhjSTNabm9MbFVHTzY0TlU2VXFISFR2emhKX2NwOWRReXlwMlU1Vk1ULWpNWDJxcE9mZnRPOXFnWDhWUnQ1VDVBUVlYZmJ6Wm1tZ0lER3hnV2pWd2RCM1h0LWx5NnE1bDVLRy1rN3lUUUpsR1c1aFhTLVFCY1pZQTNUM3ZFOXgtSTBwU0dDdjFLaHpjQlo2dUZVUWt3eTlKVFN4R0NBUzQxQ1V0ejB2czkxc3ptc2FBVlBEaWVWT1N5SVNaWWctS3Y1UVE?oc=5","date":"2025-04-21","type":"pipeline","source":"prnewswire.com","summary":"Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight - prnewswire.com","headline":"Roche's HEMLIBRA Achieves Significant Uptake Across Key Hemophilia A Markets | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPYTBCUzJmNGN5WHZ0VFM5aThrNzdDeVhtdDJMRDVXVEtzTGN1M0FyVkVtMEpGWVpTUmJTd3RKN2dBYzM3RDZ0WHpNbUMxN2d3eVpRelR4MXdVRGMySGJzZk9qZ215WkJoS0x1Yzk4dDI0VTVGX21lUDNyYVg4bHd5Q3BoYkpUVVh5?oc=5","date":"2025-03-17","type":"pipeline","source":"statnews.com","summary":"These 12 Chinese companies are poised to transform CRISPR gene-editing - statnews.com","headline":"These 12 Chinese companies are poised to transform CRISPR gene-editing","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxPMnhpMVAxUVYxT3kxYmZhQWp5Q1pKbElfMEQwa2tKT1NMVjVYdEdNT19zYWZaUDY3LXVObXhQUTJ0MmFsdjFzeXBVcklhTEc4RmNxWnpFZU1FV0toU2NDVlh5OG5uU3hLTWF5LTZDYnRCTDFsUmlYSlY5NktYMVptMDZRUDRxMVgwamZKa3YzTHRXQTJOUXRjSWZfMS1EZ0tUbUlUSzZzb3NlbUZ1RGNoX0ZjaWtkWDdBbk9uUUg4bUJyYTlhaF9ESlhsOU52ZExfcXZqczB1c0FMeUl3dy0tdzF1OWZhTW9ZcU9zemJyakhneTA?oc=5","date":"2025-02-25","type":"pipeline","source":"prnewswire.com","summary":"Global Advanced Therapy Medicinal Products Market to Grow Immensely at a CAGR of ~14% by 2032 | DelveInsight - prnewswire.com","headline":"Global Advanced Therapy Medicinal Products Market to Grow Immensely at a CAGR of ~14% by 2032 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxPVkRMZTFPNWRnTEliZmx2X2haQUE0ZHJ6TWlGM1V4OElCRjVGMVE4VlpSN0NKLW5hd1pZbHR3QWFQbU1NUHAyWldwd0ZaTVpMY1ZBaFlWU3ZZbHpZVkJsRUtEWnB6XzIyTFlPRGdYVmpHakR6RUVWdWxVcnppcm9neEtOaGIwT0lUZnFrWXJ4TmhuVlZlU1pUcEl2X0Z3VERmdW1ydXA1RmR3WkxqZUtwTUpYTkFISU94YjRYSGRCZnNfaUhRV1l3SzhIN29yd1hGblhqa2lVOEFLMXlxeU1FUVo5clhTY1JpMjUzbFpyOFVxMGctczBwZlZNTjJJMjgwSnppaGM1T2pJbjdBckV4ZnRtTTZVVUl1cG1mS1hlX2w?oc=5","date":"2024-10-22","type":"trial","source":"GlobeNewswire","summary":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+ - GlobeNewswire","headline":"Gene Therapy Clinical Trial Pipeline Gains Momentum: 180+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivwFBVV95cUxNQVpPZ25mOXo4RnhvaWJaSExmbnYxY0xlcEQ4aENpXzhtd21sSWp4Uk43UjhfMFloRWFtbFVKQnZqcjdWZFk0bzJfZ0FzMjZoLXhmbWVMNVZ1T1NaVGRRelA0cG1qejBfdTFoWFMtY2FhYXNXUjNyc1o3Mjh3NjZhVVhUMXBvcTBSVmRQcUx0SHRnU21LM3lMU2paQzB3ZnZIbnp3Y01Ec2JpOWtxYkxLMGI4aWJpOXlOMndmV1RUZw?oc=5","date":"2024-01-17","type":"regulatory","source":"Clinical Trials Arena","summary":"Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval - Clinical Trials Arena","headline":"Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval","sentiment":"positive"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}